STAAR试验:电子依从性监测联合提醒与反馈改善哮喘患儿临床结局
STAAR随机对照试验纳入6-16岁控制不佳的哮喘患儿,比较电子依从性监测联合每日提醒闹钟及门诊反馈与单纯监测的差异。干预组吸入激素依从性70%高于对照组49%(p≤0.001),ACQ变化无显著差异,但干预组口服激素疗程和住院次数显著减少。
要点
- 电子监测联合提醒与反馈使哮喘患儿ICS依从性从49%提升至70%。
- 干预未显著改善ACQ评分,但减少了口服激素疗程和住院。
- 对控制不佳的哮喘患儿,该干预可能具有常规管理价值。
核心结论
- 电子依从性监测联合反馈可能对控制不佳哮喘患儿的常规管理有显著益处。
研究设计与样本
- 随机对照试验,6-16岁控制不佳哮喘患儿随机分为干预组(电子监测+每日提醒闹钟+门诊反馈)和对照组(仅监测),每3个月随访1次共1年。
- 90名儿童中77名完成研究(干预组39例,对照组38例)。
主要发现
- 干预组依从性为70%,对照组为49%(p≤0.001)。
- ACQ变化两组间无显著差异。
- 干预组口服激素疗程显著更少(p=0.008),住院次数显著更少(p≤0.001)。
临床怎么用
- 对控制不佳的哮喘患儿,可考虑引入电子依从性监测联合提醒和门诊反馈以改善依从性并减少口服激素和住院。
局限性
- 完成研究的样本量较小(77例),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Suboptimal adherence to inhaled steroids is common in children with asthma and is associated with poor disease control, reduced quality of life and even death. Previous studies using feedback of electronically monitored adherence data have demonstrated improved adherence, but have not demonstrated a significant impact on clinical outcomes. The aim of this study was to determine whether introduction of this approach into routine practice would result in improved clinical outcomes. METHODS: Children with asthma aged 6-16 years were randomised to the active intervention consisting of electronic adherence monitoring with daily reminder alarms together with feedback in the clinic regarding their inhaled corticosteroid (ICS) use or to the usual care arm with adherence monitoring alone. All children had poorly controlled asthma at baseline, taking ICS and long-acting β-agonists. Subjects were seen in routine clinics every 3 months for 1 year. The primary outcome was the Asthma Control Questionnaire (ACQ) score. Secondary outcomes included adherence and markers of asthma morbidity. RESULTS: 77 of 90 children completed the study (39 interventions, 38 controls). Adherence in the intervention group was 70% vs 49% in the control group (p≤0.001). There was no significant difference in the change in ACQ, but children in the intervention group required significantly fewer courses of oral steroids (p=0.008) and fewer hospital admissions (p≤0.001). CONCLUSIONS: The results indicate that electronic adherence monitoring with feedback is likely to be of significant benefit in the routine management of poorly controlled asthmatic subjects. TRIAL REGISTRATION NUMBER: NCT02451709; pre-result.
引用
- Morton RW, Elphick HE, Rigby AS, et al. STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax. 2016. PMID: 27815524. doi:10.1136/thoraxjnl-2015-208171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。